BBlogFlow

Top Issues for British Columbians - Ipsos

·Sep 18, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Ipsos

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Health care ranked as the top priority for British Columbians ahead of provincial election - Doctors of BC

New polling shows leading concerns include reducing specialist wait times, strengthening the health care workforce, and improving access to primary and emergency care. With British Columbians heading to the polls on October 24, new polling commissioned by Doctors of BC, BC Family Doctors, and Consultant Specialists of BC shows that health care is the most important issue facing people across the province, reinforcing the need for parties to clearly outline their health care commitments during the provincial election campaign. The Leger360 poll found 28% of British Columbians identified health care as either the most (15%) or second-most (13%) important issue facing BC, ahead of housing and affordability (26%) and the economy (23%).

Doctors of BC·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·